average weight loss in 3 months on semaglutide for Loss: How It Works, Comparisons, and More Our weight management program: 12

The STEP-1 extension trial followed patients who had lost weight on semaglutide and then switched to placebo

Among adults who have used these drugs, seven in ten say they used them primarily to treat a chronic condition like diabetes or heart disease (38%) or to both treat a chronic condition and lose weight (32%), while three in ten GLP-1 users (30%) report using these drugs primarily to lose weight

These changes are usually related more to weight loss than to a toxic effect of the drug itself

The hypothalamic-pituitary-adrenal and the GH/IGF-I axis are also closely associated, as cortisol is required for physiological GH secretion

Importance of Safety and Transparency Without thorough safety testing and transparent labeling, these products may pose unnecessary health risks